Designation: General manager
Gam assumed her current role in 2018. Cytopharma is the first company in Africa and the Middle East to exclusively manufacture and market generic anti-cancer drugs. In May 2022, the company secured an EU Good Manufacturing Practices certification. Gam has over 25 years of experience in the pharmaceutical and biotech industry. Before CytoPharma, she held roles at Aventis and Catalent in Europe. She is also a board member at Julphar.